Snowden Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Snowden Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Sell	3,962 -1,296	-25%	-$114K	0.01%	1017
2026 Q1	$477K	Sell	5,258 -218	-4%	-$20K	0.01%	820
2025 Q4	$494K	Sell	5,476 -61	-1%	-$5.78K	0.01%	814
2025 Q3	$547K	Sell	5,537 -98	-2%	-$9.71K	0.01%	735
2025 Q2	$515K	Buy	5,635 +674	+14%	+$65.2K	0.02%	751
2025 Q1	$563K	Buy	4,961 +99	+2%	+$10.6K	0.02%	690
2024 Q4	$515K	Buy	4,862 +2,227	+85%	+$239K	0.02%	761
2024 Q3	$285K	Sell	2,635 -676	-20%	-$73.8K	0.01%	1017
2024 Q2	$360K	Sell	3,311 -369	-10%	-$43.5K	0.01%	895
2024 Q1	$487K	Sell	3,680 -145	-4%	-$18.1K	0.02%	775
2023 Q4	$466K	Sell	3,825 -374	-9%	-$41.7K	0.02%	727
2023 Q3	$471K	Sell	4,199 -3,166	-43%	-$402K	0.02%	681
2023 Q2	$1.07M	Sell	7,365 -825	-10%	-$112K	0.04%	441
2023 Q1	$1.06M	Buy	8,190 +18	+0.2%	+$2.26K	0.04%	444
2022 Q4	$1.04M	Buy	8,172 +750	+10%	+$87K	0.04%	440
2022 Q3	$775K	Buy	7,422 +1,620	+28%	+$178K	0.04%	493
2022 Q2	$609K	Buy	5,802 +768	+15%	+$91.1K	0.03%	553
2022 Q1	$643K	Buy	5,034 +3,613	+254%	+$436K	0.03%	548
2021 Q4	$175K	Sell	1,421 -1,461	-51%	-$191K	0.01%	696
2021 Q3	$410K	Buy	2,882 +57	+2%	+$8.38K	0.02%	589
2021 Q2	$441K	Buy	2,825 +29	+1%	+$4.7K	0.02%	579
2021 Q1	$435K	Buy	2,796 +1,245	+80%	+$193K	0.02%	526
2020 Q4	$232K	Buy	+1,551	New	+$219K	0.02%	593

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Snowden Capital Advisors's ZBH Position: Q2 2026 in Review

Snowden Capital Advisors reduced its Zimmer Biomet (ZBH) stake by 25% in Q2 2026, selling an estimated $114K and leaving 3,962 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #1017.

Snowden Capital Advisors first reported a position in ZBH in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.07M in Q2 2023. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Snowden Capital Advisors held 3,962 shares of Zimmer Biomet worth $342K as of Q2 2026.
Snowden Capital Advisors sold 1,296 Zimmer Biomet shares in Q2 2026, an estimated $114K.
Zimmer Biomet made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1017 holding.
Snowden Capital Advisors first reported a position in Zimmer Biomet in Q4 2020 and has held it in 23 quarters since.
Snowden Capital Advisors's Zimmer Biomet position peaked at $1.07M in Q2 2023.
910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.